{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:04:26Z","timestamp":1793916266740,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005039","name":"Leiden University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007423","name":"Duchenne Parent Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nmd.2025.105394","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T02:29:43Z","timestamp":1748053783000},"page":"105394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antisense oligonucleotide-mediated redirection of Igf1 alternative polyadenylation"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4787-7980","authenticated-orcid":false,"given":"Alper","family":"Yavas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"van Putten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Ariyurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Aartsma-Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2025.105394_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.23810","article-title":"Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy","volume":"48","author":"Mendell","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105394_bib0002","doi-asserted-by":"crossref","unstructured":"Mozin E., Massourid\u00e8s E., Mournetas V., Li\u00e8vre C., Bourdon A., Jackson D.L., et al. Dystrophin deficiency impairs cell junction formation during embryonic myogenesis. bioRxiv. 2023. Epub 2023\/12\/18. doi: 10.1101\/2023.12.05.569919. PubMed PMID: 38106055; PubMed Central PMCID: PMCPMC10723310.","DOI":"10.1101\/2023.12.05.569919"},{"issue":"8","key":"10.1016\/j.nmd.2025.105394_bib0003","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4103\/1673-5374.253534","article-title":"Regenerative biomarkers for Duchenne muscular dystrophy","volume":"14","author":"Guiraud","year":"2019","journal-title":"Neural Regen Res"},{"issue":"11","key":"10.1016\/j.nmd.2025.105394_bib0004","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/21678707.2016.1240613","article-title":"Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy","volume":"4","author":"Spinazzola","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"issue":"8","key":"10.1016\/j.nmd.2025.105394_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081773","article-title":"Implications of insulin-like growth factor-1 in skeletal muscle and various diseases","volume":"9","author":"Ahmad","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.nmd.2025.105394_bib0006","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tem.2013.03.004","article-title":"The therapeutic potential of IGF-I in skeletal muscle repair","volume":"24","author":"Song","year":"2013","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.nmd.2025.105394_bib0007","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ghir.2012.02.004","article-title":"Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy","volume":"22","author":"Gehrig","year":"2012","journal-title":"Growth Horm IGF Res"},{"issue":"5","key":"10.1016\/j.nmd.2025.105394_bib0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ghir.2014.06.003","article-title":"Optimizing IGF-I for skeletal muscle therapeutics","volume":"24","author":"Philippou","year":"2014","journal-title":"Growth Horm IGF Res"},{"issue":"7","key":"10.1016\/j.nmd.2025.105394_bib0009","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrg3482","article-title":"Alternative cleavage and polyadenylation: extent, regulation and function","volume":"14","author":"Elkon","year":"2013","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.nmd.2025.105394_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/en.2012-1476","article-title":"IGF-I 3\u2032 untranslated region: strain-specific polymorphisms and motifs regulating IGF-I in osteoblasts","volume":"154","author":"Smith","year":"2013","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.nmd.2025.105394_bib0011","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1261\/rna.2581711","article-title":"Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq","volume":"17","author":"Shepard","year":"2011","journal-title":"Rna"},{"issue":"1","key":"10.1016\/j.nmd.2025.105394_bib0012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12860-019-0230-3","article-title":"lncRNA H19 promotes matrix mineralization through up-regulating IGF1 by sponging miR-185-5p in osteoblasts","volume":"20","author":"Wu","year":"2019","journal-title":"BMC Mol Cell Biol"},{"issue":"23","key":"10.1016\/j.nmd.2025.105394_bib0013","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.109.879429","article-title":"Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions","volume":"120","author":"Elia","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.nmd.2025.105394_bib0014","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nmd.2011.07.008","article-title":"A single 30min treadmill exercise session is suitable for \u2018proof-of concept studies\u2019 in adult mdx mice: a comparison of the early consequences of two different treadmill protocols","volume":"22","author":"Radley-Crabb","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"Pt 1","key":"10.1016\/j.nmd.2025.105394_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.0021-8782.2001.00008.x","article-title":"Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability","volume":"200","author":"Hamer","year":"2002","journal-title":"J Anat"},{"issue":"1","key":"10.1016\/j.nmd.2025.105394_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51470-9","article-title":"Transcriptome profiling of mouse samples using nanopore sequencing of cDNA and RNA molecules","volume":"9","author":"Sessegolo","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2025.105394_bib0017","series-title":"The igf system: molecular biology, physiology, and clinical applications","first-page":"497","article-title":"IGFs and Skeletal Muscle","author":"Rosenthal","year":"1999"},{"issue":"1","key":"10.1016\/j.nmd.2025.105394_bib0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1083\/jcb.200108071","article-title":"Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice","volume":"157","author":"Barton","year":"2002","journal-title":"J Cell Biol"},{"issue":"5","key":"10.1016\/j.nmd.2025.105394_bib0019","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ymthe.2004.07.026","article-title":"Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice","volume":"10","author":"Shavlakadze","year":"2004","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.nmd.2025.105394_bib0020","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.1152\/ajpendo.00101.2006","article-title":"Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice","volume":"291","author":"Schertzer","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.nmd.2025.105394_bib0021","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0002-9440(10)64502-6","article-title":"Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration","volume":"161","author":"Gregorevic","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2025.105394_bib0022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.nmd.2025.105394_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/srep38371","article-title":"Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA\/2 background","volume":"6","author":"Rodrigues","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.nmd.2025.105394_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/cells9091970","article-title":"Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy","volume":"9","author":"Yoshida","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.nmd.2025.105394_bib0025","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaci.2021.09.039","article-title":"Targeting IgE polyadenylation signal with antisense oligonucleotides decreases IgE secretion and plasma cell viability","volume":"149","author":"Marchalot","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.nmd.2025.105394_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051347","article-title":"Targeting the polyadenylation signal of Pre-mRNA: a new gene silencing approach for facioscapulohumeral dystrophy","volume":"19","author":"Marsollier","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.nmd.2025.105394_bib0027","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/nar\/29.6.1293","article-title":"Fully modified 2\u2032 MOE oligonucleotides redirect polyadenylation","volume":"29","author":"Vickers","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.nmd.2025.105394_bib0028","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1152\/ajpendo.00253.2002","article-title":"Skeletal muscle IGF-binding protein-3 and -5 expressions are age, muscle, and load dependent","volume":"284","author":"Spangenburg","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.nmd.2025.105394_bib0029","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fnut.2019.00146","article-title":"The role of the IGF-1 signaling cascade in muscle protein synthesis and anabolic resistance in aging skeletal muscle","volume":"6","author":"Barclay","year":"2019","journal-title":"Front Nutr"},{"issue":"12","key":"10.1016\/j.nmd.2025.105394_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189642","article-title":"Diversification of the insulin-like growth factor 1 gene in mammals","volume":"12","author":"Rotwein","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.nmd.2025.105394_bib0031","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4161\/nucl.36360","article-title":"Implications of polyadenylation in health and disease","volume":"5","author":"Curinha","year":"2014","journal-title":"Nucleus"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662500121X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662500121X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:08:21Z","timestamp":1762344501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089662500121X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":31,"alternative-id":["S096089662500121X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105394","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisense oligonucleotide-mediated redirection of Igf1 alternative polyadenylation","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105394"}}